Q-linea AB announced that the company has received an awarding of a public tender for rapid AST instruments and consumables issued by Fondazione PTV - Tor Vergata in Rome, Italy. The tender has a validity for five years and a total value of EUR 600,000 and the company expects the formalization of the awarding in 35 days. The equipment will be used at the Policlinico Tor Vergata University of Rome.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 SEK | -2.16% | -7.72% | -38.65% |
04-26 | Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System | CI |
03-13 | Q-linea AB Presents Strong ASTar Results At AMCLI | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.65% | 24.47M | |
-16.33% | 18.62B | |
+22.02% | 1.94B | |
+0.39% | 1.68B | |
+27.15% | 1.26B | |
-10.70% | 1.03B | |
-18.27% | 938M | |
+0.66% | 783M | |
-25.07% | 628M | |
+14.62% | 535M |
- Stock Market
- Equities
- QLINEA Stock
- News Q-linea AB
- Q-Linea Wins Public Tender for Rapid AST